Cubist Systematic Strategies, LLC Compugen LTD Transaction History
Cubist Systematic Strategies, LLC
- $20.3 Billion
- Q2 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Compugen LTD stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 10,154 shares of CGEN stock, worth $17,769. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,154
Previous 16,062
36.78%
Holding current value
$17,769
Previous $23,000
21.74%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CGEN
# of Institutions
79Shares Held
16.3MCall Options Held
59.3KPut Options Held
32.1K-
Silverarc Capital Management, LLC3.03MShares$5.31 Million1.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.33MShares$2.32 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.31MShares$2.3 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.07MShares$1.88 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.79 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $152M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...